The differentiation-dependent expression of purinergic receptors for metaboiicaiiy stable analogues of adenosine and ATP was studied in human mononuclear phagocytes (MNPs). Iigands of these receptors are able to modulate cellular cholesterol metabolism. In addition, the intracellular signal transduction pathways of the purinergic receptor system were examined. ATPyS, the metabolic stable analogue of ATP, was used as a P 2 ligand, and 2-p-(2-carboxyethyl)phenylethylamino-5'-A ]| in 1-and 7-day cultured human MNPs in a concentration-dependent manner, whereas the Pi Iigands, adenosine and CGS 21680, induced Ca 2+ flux only in 7-day cultured MNPs. All three drugs increased intracellular cAMP levels in 7-day cultured human MNPs at a concentration of 10~5 mol/L, whereas no effect was observed in 1-day cultured human MNPs. The uptake of fluorescently labeled acetylated low-density lipoprotein (LDL) in 7-day cultured human MNPs was inhibited by adenosine, CGS 21680, ATP, and ATPyS. No significant influence of these compounds was measured on the uptake of LDL, acetylated LDL, and high-density lipoprotein, in 1-day cultured MNPs. Our investigations indicate that the expression of P 2j and A 2 receptors is increased during differentiation of blood monocytes to macrophages. It is shown that both purinergic Iigands, ATPyS and CGS 21680, inhibit the uptake of acetylated LDL in a concentration-dependent manner, which might impair foam cell formation. (Arteriosder Thromb. 1993;13:1317-1326 KEY WORDS • monocyte/macrophages • differentiation • purinergic receptor system • signal transduction A key event in atherogenesis is the infiltration of blood monocytes in response to endothelial . injury into the subendothelial tissue.
ized on the basis of receptor-mediated signal transduction mechanisms, rank order of agonist binding, and physiological potencies.
1011 P, receptors are subdivided into A, and A 2 , and possibly A 3 , receptors. Adenylyl cyclase is inhibited at nanomolar concentrations via the A\ receptor. 12 - 13 High-and low-affinity A 2 receptors are responsible for the activation of adenylyl cyclase, thus increasing intracellular cAMP levels. 1415 Intracellular cAMP may activate cAMP-dependent protein kinases, which activate or deactivate proteins involved in cholesterol homeostasis of different cell types. It has been shown for smooth muscle cells that increases of intracellular cAMP stimulate the activity of cholesteryl ester hydrolases. 16 cAMP may also have important functions in the regulation of cytoskeletal elements involved in endocytosis and secretory processes.
On the basis of the relative affinities of ATP and a series of analogues and the structure-activity relations investigated in smooth muscle cells, the purinergic P 2 receptors have been subdivided into the P^, and P^, mediating contraction and relaxation, respectively, of smooth muscle cells. 17 As far as is known, P 2 receptors act via mobilization of [Ca 2+ ], and the phosphoinositol cycle pathway. 1819 Another second-messenger product of phospholipase C-mediated phosphoinositide hydrolysis is diacylgrycerol, which activates protein kinase C. Both Ca 2+ and protein kinase C are known to be important regulators of several metabolic enzymes involved in cellular processes, such as glycolysis, lipolysis, and secretion.
ATP increases Ca
2+ levels by mobilizing intracellular stores and activating plasma membrane Ca 2+ channels. 20 A second mecham'sm that induces an increase of [Ca 2+ ], in macrophages is obviously provoked by ATP*~, which activates ion channels and permeabilizes the plasma membrane. 21 The concentration of ATP and adenosine in plasma is usually low. ATP is released from endothelial cells during hypoxia and by the dense granules of blood platelets during aggregation. A major regulator of plasma ATP and adenosine concentrations is the red blood cell. Under certain pathological conditions, red blood cells can release large amounts of ATP and ADP. 22 Furthermore, purinergic ligands are known to be involved in inflammatory and atherosclerotic processes 9 and to regulate functions such as adhesion, 23 oxidative burst, 24 and phagocytosis. 25 Even though it is known that exposure of macrophages to ATP leads to membrane depolarization, 26 monovalent cation fluxes, 21 increase in F c -mediated phagocytosis, 27 and mononuclear phagocyte (MNP) adherence to endothelial cells, 28 the expression of purinergic receptors on monocytes or macrophages has not been investigated in detail. The aim of this study was to characterize the expression and function of this receptor family on monocytes and macrophages and their potential role in atherogenesis.
Methods

Materials
Nutridoma-NS (serum-free medium supplement) was from Boehringer, Mannheim, FRG. Hank's medium and fetal calf serum were from GEBCO, Eggenstein, FRG. Adenosine, ATP, stable analogues of ATP, fura 2-AM, digitonin, EGTA, Tricine, and potato starch were from 
Isolation and Cultivation of Human MNPs
For binding assays, monocytes were isolated from the blood of normolipidemic donors. 29 The white blood cells were collected by leukapheresis in a Cobe cell-separator system. Aliquots of this cell suspension were mixed with 6% dextran G-500 in a ratio of 10:1, and remaining red blood cells were allowed to settle at room temperature. The cells of the supernatants were pooled and centrifuged at 400g for 10 minutes. The cells were resuspended in 15 mL Hank's buffer containing 0.5% human serum albumin and were injected into a Beckman JE-6 elutriator rotor with a standard separation chamber at a flow rate of 7 mL/min and a rotor speed of 2.040 rpm at 15°C. This was followed by 100 mL Hank's buffer/0.5% human serum albumin at a flow rate of 9 mL/min. Fractions 2 to 7 (50 mL each) were collected at flow rates of 12, 15, 18, 20, 22 , and 24 mL/min. Aliquots of the fractions were analyzed with a FACScan (Becton Dickinson, Heidelberg, FRG), and fractions containing 90% monocytes, identified as CD14-positive cells, were pooled, washed, and cultured for 1 day on 35x10-mm dishes or for 7 days in hydrophobic Teflon bags in RPMI 1640 medium supplemented with 1% Nutridoma-NS. 30 For binding studies, the cells were removed from Teflon bags, adjusted to 10 6 cells/mL, and incubated for 2 hours at 37°C. Then the cells were washed to remove the nonadherent cells.
Flow Cytometric Determination of Surface Markers
Human MNPs were removed from Teflon bags, washed with ice-cold phosphate-buffered saline (PBS) containing 0-5% bovine serum albumin (BSA), and adjusted to 10 6 cells per milliliter. FITC-or PE-labeled antibody (10 jiL) was added to 200 /xL of cell suspension and incubated for 60 minutes on ice. The samples were washed twice with PBS/0.5% BSA. For flow cytometric determination, 300 ML PBS/0.5% BSA was added to the samples. The measurements were performed on a FACScan (Becton Dickinson) equipped with a 15-mW argon laser, operating at a 488-nm excitation wavelength. Fluorescence of FITC was measured at 530 nm; PE, at 580 nm. Forward-vs sidescatter gates were set to exclude lymphocytes and dead cells. Fluorescence signals were recorded to produce a histogram of the gated monocytes vs relative fluorescence intensity after logarithmic amplification. The results were expressed as mean fluorescence of the gated monocytes.
Receptor Binding Assays
To 
Determination of Intracellular Ca 2+ Levels
Human MNPs (10 7 cells per milliliter) were suspended in PBS containing (mmol/L) NaCl, 125; KC1, 5; KH 2 PO 4 ,1; NaHCO 3 ,1; CaCl 2 ,1 (pH 6.9); glucose, 5.5; and N-2-hydroxyethylpiperazine-A r '-2-ethanesulfonic acid, 10. For fura 2-AM loading, 1 /xmol/L fura 2-AM was added to the cells and incubated for 1 hour at 37°C, and then after washing away the remaining dye, the cells were incubated for 20 minutes at 20°C. After washing the cells twice with PBS, they were diluted to 5xlO 6 cells per milliliter for the measurements. All incubation and washing procedures were performed in the dark. Fluorescence measurements were done in a Hitachi fiuorescence-spectrophotometer equipped with a thermostatically controlled cuvette holder and a magnetic stirrer. The excitation-emission wavelength pairs used to monitor dye fluorescence were 340 nm (Al) and 380 nm (A2). [Ca 2+ ]i was calculated with the general formula 31 implemented in the special software provided by Colora: [Ca 2+ ],=/C d (R-R mln )/(R mM -R)F nJn , A2) /F nilI(A2) , where K^ is the dissociation constant for Ca 2+ binding (135 nmol/L for fura 2 at 20°C), R is the measured fluorescence in arbitrary units, F^ is the fluorescence after lysis of the cells with 0.05% digitonin in the presence of 5 mmol/L EGTA and 40 mmol/L Tris (final pH of 8.5), and F^ is the fluorescence of the lysed cells at saturated Ca 2+ concentration. F was corrected for the following factors: The autofluorescence of unloaded cells and added reagents was determined and was negligible (<10%). Dye leakage and secretion from cells was minimized by washing the cells directly before the measurement.
Determination of Intracellular cAMP and cGMP Levels
Intracellular cAMP and cGMP levels were determined by a commercially available radioimmunoassay from IBL, Hamburg, FRG. 32 The assays were performed according to the instructions of the manufacturers. After the incubation time, the cells were immediately frozen in liquid nitrogen. The cyclic nucleotides were extracted by 60% acetonitrile for 30 minutes.
Isolation and Preparation of Lipoproteins
Human LDL (d, 1.019 to 1.063 g/mL) was isolated from the sera of individual normolipidemic volunteers by sequential ultracentrifugation, according to a method previously described, 33 in a Beckman L8 70 ultracentrifuge at 4°C with a 50.3 Ti or 70 Ti rotor (Beckman). The lipoprotein fractions were dialyzed against 0.15 mol/L NaCl at 4°C. All concentrations of lipoproteins are given in terms of their protein content with albumin as a standard.
Chemical Modification of LDLs
LDLs were acetylated by repeated additions of acetic acid anhydride and were dialyzed against PBS (pH 7.4) at 4°C. 34 The modified LDLs showed enhanced mobility on agarose gel electrophoresis at pH 8.6.
Preparation of Fluorescentfy Labeled Lipoproteins
LDL, acetylated LDL (AcLDL), and high-density lipoprotein 3 (HDL3) were labeled with Dil according to a method previously described. 35 Fifty milligrams lipoprotein in 5 mL of 0.9% NaCl/0.3 mmol/L EDTA were dialyzed against 0.3 mmol/L EDTA at 4°C. To the aliquots of 2 mg lipoprotein, 25 mg potato starch was added and then lyophilized. The neutral lipids were extracted three times with heptane at -10°C. To the remaining pellet, 4.5 mg Dil in a volume of 400 JAL heptane was added and incubated for 2 hours at -20°C. The mixture was dried under N 2 , then resuspended in 1 mL of 10 mmol/L Tricine and 100 mg/L NaN 3 , pH 8.2, incubated for 48 hours at 4°C, and centrifuged for 10 minutes at 900g at 4°C. The supernatant containing the fluorescently labeled lipoproteins was used for the experiments.
Flow Cytometric Determination of Uptake of Dil-Labeled Lipoproteins
One-day cultured and 7-day cultured human MNPs were incubated with Dil-labeled lipoproteins according to the conditions indicated in the figure legends. Dillipoprotein-labeled cells were analyzed in a Becton Dickinson FACScan. Cellular accumulation of Dil was measured at 580 nm in samples containing at least 10 000 cells. Autofluorescence of unlabeled cells was subtracted.
Protein Determination
Determinations of cellular proteins and lipoproteins were performed according to the method of Lowry et al. 36 
Results
In Vitro Differentiation of Human MNPs
The surface expression of differentiation antigens was determined in 1-and 7-day cultured human MNPs as described in "Methods." 30 One-day cultured MNPs represent a more homogenous population characterized by a relatively small volume and minor granularity in comparison with 7-day cultured MNPs (data not shown). More than 80% of the cells were viable after the cultivation procedure. For further analysis, dead cells were excluded by electronic gating. As parameters for differentiation, three differentiation antigens were measured on 1-, 3-, 5-, and 7-day cultured human MNPs protein (data not shown). These results indicate that 1-day cultured human MNPs do not respond to signals induced by adenosine in the surrounding milieu; however, differentiated human MNPs are particularly sensitive to adenosine, since they express adenosine A 2 receptors.
Competition studies were also performed between ATP-yS binding and CGS 21680, but no displacement could be measured, indicating two different binding sites (data not shown).
Characterization ofP 2 Receptors on 1-and 7-Day Cultured Human MNPs
To characterize the P 2 receptor, the metabolically stable analogue of ATP, [ To investigate the subtype of P 2 receptors on human MNPs, competition studies were also performed between pS]ATP-yS binding and the P^ receptor-specific ligands a,/3-me-ATP and 0,-y-me-ATP. Competitive displacement of the radiolabeled ligand was not detected in any of the experiments (data not shown), indicating that the receptor subtype is not a Pj, receptor. The Pj, receptor type has been found only on smooth muscle cells mediating contraction. 
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in 7-day cultured human mononuclear phagocytes upon addition of ATPyS (A) and 2-p-(2-carboxyethyl)phenylethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680, B). Drugs were added after 200 seconds. For further experimental details, see "Methods."
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Signal Transduction Pathways of the Purinergic Receptor System: Measurement of IntraceUular Ca 2 * Levels
As far as is known, P 2 receptors act via the phosphoinositol cycle pathway and the mobilization of Ca 2+ . Therefore, the intracellular Ca 2+ level in human MNPs was measured to investigate the signal transduction pathway of the characterized binding site of ATPyS.
On 1-day cultured MNPs, the P 2 ligands ATPyS and ATP induce a transient Ca 2+ flux in a concentrationdependent manner. The average of [Ca 2+ ]j in 1-and 7-day cultured human MNPs was 65 nmol/L (range, from 37 to 85 nmol/L). Addition of ATPyS to the cells induced a rapid transient increase of [Ca 2+ ] f (Fig 3A) . This response was dose dependent in 1-and 7-day cultured human MNPs. The maximum response was reached in less than 20 seconds and regained the original baseline within 200 seconds. This ATPyS-induced rise in [Ca 2+ ]i is also seen when EGTA is added to the cells 1 minute before the addition of ATPyS. Therefore, it can be excluded that the observed signal is due to the activation of Ca 2+ channels located in the plasma membrane. The increase of [Ca 2+ ], by ATPyS is similar in its time course to that of ATP, indicating that the short duration of the signal is not due to degradative inactivation by ectonucleotidases but rather to intracellular compensatory reactions. The maximal increase of [Ca 2+ ],, however, is lower than for ATP itself ( Table 2) .
The specific analogues o,£-me-ATP and /3,-y-me-ATP, which preferentially interact with P^-type receptors, 42 do not induce an increase of [Ca 2+ ], either in 1-or in 7-day cultured human MNPs (Table 2 ). This indicates that the purinergic receptor is not of a P^ type in human MNPs.
Usually, adenosine and its analogues are supposed to decrease intracellular Ca 2+ levels. In 1-day cultured human MNPs, adenosine and the analogue CGS 21680 do not increase Ca 2+ levels, which is consistent with our findings that no P] receptors are expressed in undifferentiated cells (Fig 3B) . In 7-day cultured human MNPs, adenosine and CGS 21680 raise Ca 2+ levels similar to those produced by ATP-yS (Table 2 ) but in a more sustained time scale until the original baseline is reached again (Fig 3B) .
Measurement of Intracellular cAMP and cGMP Levels
cAMP plays a major role as a second messenger in cellular processes involved in atherogenesis. Therefore, the effects of P, and P 2 ligands on cytosolic cAMP levels were tested. Neither adenosine, CGS 21680, nor ATPyS changed [cAMP], in 1-day cultured MNPs (data not shown), indicating that these cells do not express A, and A 2 receptors at this stage of differentiation. This is in accordance with our binding experiments, in which no specific binding of CGS 21680 could be determined. In contrast, differentiated MNPs showed a dose-dependent cAMP increase in response to the A 2 agonist CGS 21680 (Fig 4) . ATPyS also enhanced the intracellular cAMP level, but only at high concentrations (10~5 mol/L) and to a smaller extent. These data are consistent with an effect on A 2 receptors as expected. In addition, the influence of these purinergic ligands on intracellular cGMP levels was measured. No significant dose-dependent changes were observed (data not shown).
cells (7-day cultures) after incubation for 90 seconds with different concentrations of ATPyS (y,S-ATP) and 2-p-(2-carboxyethyl)phenylethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680
Inhibition of Dil-Labeled AcLDL Uptake by Purinergic Ligands
Foam cell formation induced by massive lipid accumulation in MNPs is a hallmark of atherogenesis. Hence, it was of interest to measure the influence of different compounds acting via purinergic receptor sites on the uptake of different lipoproteins. One-day and 7-day cultured human MNPs were incubated with different concentrations of ATPyS and CGS 21680. Because 1-day cultured human MNPs do not express adenosine A 2 receptors, no significant consistent effect on lipoprotein uptake was obtained. In 7-day cultured MNPs, however, the uptake of Dil-AcLDL was considerably inhibited by both compounds, whereas Dil-LDL and Dil-HDL, uptake were not significantly altered ( Fig  5) . Furthermore, other ligands also acting on the purinergic receptor system, such as adenosine and the nonmetabolizable ATP analogues a,/3-me-ATP and /3,-y-me-ATP, were tested for their ability to inhibit the uptake of Dil-AcLDL on 7-day cultured human MNPs (Fig 6) . Inhibition of Dil-AcLDL uptake was obtained for all compounds. The A 2 receptor ligands were the most effective agents (25% inhibition). These experiments show that the A 2 receptor and possibly the Pr eceptor inhibit the uptake of chemically modified lipo- proteins by the scavenger receptor in differentiated human MNPs.
FlG 5. Bar graphs show the influence of ATPyS (A) and 2-p-(2-carbaxyethyl)phenylethylamino-5'-fi-ethykarboxamidoadenosine (CGS 21680, B) on the uptake of3,3'-dioctadecylindocarbocyanine iodide (Dil) -labeled lipoproteins on 7-day cultured human mononuclear phagocytes measured by flow cytometry. AcLDL indicates acetylated low-density lipoprotein (LDL); HDL
Discussion
The infiltration of blood monocytes into the subendothelial tissue in response to various noxious stimuli on the endothelial cell layer is an important early event in atherogenesis.
143 LDL, the major cholesterol transporter, and especially modified LDL initiate the chemotactic attraction of circulating blood monocytes 44 and stimulate maturation into resident macrophages. 8 Therefore, it is of special interest to investigate the effects of purinergic ligands, which are known to be involved in maturation processes, 39 on cholesterol metabolism 16 at different stages of differentiation. The in vitro maturation of human MNPs was performed under defined conditions by cultivation on hydrophobic Teflon foils according to a modified method of Kreutz et al. 30 During this cultivation procedure, the cells changed their phenotypic behavior to a more heterogeneous population of large, well-spread macrophages accompanied by a strong expression of CD14, CD16, and HLA-DR antigens (Table 1) . The nature of the Pi receptors and the signal transduction mechanisms was explored in detail. The typical agonists for probing A] receptor subtypes, however, did not bind to 1-and 7-day cultured human MNPs. There were also no intracellular signals such as reduction of cAMP levels. Therefore, it is concluded that human MNPs do not express adenosine Aj receptors, which is consistent with findings in other blood cells. The new adenosine A 2 agonist CGS 21680 also showed no binding or intracellular signaling in 1-day cultured human MNPs. However, in 7-day cultured human MNPs, a biphasic, saturable, and reversible binding curve of CGS 21680 occurred (Fig 1) . The binding data can only be fitted by the LIGAND-PC software in a two-receptor model. Using a one-or three-receptor model, no meaningful data were obtained. The K^ values of the highaffinity range were similar to that of platelet membranes, which are known to express only A 2 receptors. 45 In the human brain also, a biphasic binding curve was measured; however, K d values were 10 and 700 nmol/L. 46 In different tissues, high-and low-affinity binding sites for ["SJATP-yS, a P 2 receptor ligand, have been reported. 4142 ' 47 The high-affinity sites range within a Kô f 30 to 40 nmol/L and the low-affinity sites have a Kv alue of 800 to 900 nmol/L for the heart and liver and 3 /imol/L for smooth muscle cells. 41 Our data indicate the presence of a low-affinity P^ receptor on 1-and 7-day cultured human MNPs (Fig 2) . During the cultivation time, B. MJ increased twofold. Klotz 4 * proposed that Scatchard analysis of ligand binding is only valid if an S-shaped curve for binding is obtained. This was not possible in the present investigation because very high ligand concentrations would have been needed. This is only feasible with, for example, isolated membrane fractions. In cell culture, toxic drug effects are prohibitive. Thus, the actual number of binding sites may be overestimated as outlined by Klotz. The conclusions drawn are not based on absolute receptor numbers. Therefore, the limitations of Scatchard analysis should be taken into account but do not change the interpretation of the present data.
Since in MNPs the traditionally used A 2 agonist NECA did not exhibit specific binding and did not compete with CGS 21680 binding, it was not possible to probe the characteristic affinity ranking with other ligands. CGS 21680 increased intracellular cAMP levels, indicating that in fact the binding curve represents A 2 receptor sites (Fig 4) . The structural difference between NECA and CGS 21680 is an additional substitution in the 2' position of the purine ring system. It cannot be excluded that, in addition to specific structural requirements of this A 2 -binding site, a different tertiary structure of the receptor, different receptor subtypes, or different binding epitopes might also be responsible for these observations. Many physiological changes occur during in vitro culture of MNPs; these changes have been considered to represent differentiation of monocytes into a macrophage-like cell type. 30 The virtual absence of adenosine receptors in circulating monocytes and the maturational expression of these receptors during differentiation may represent an additional marker and a selective regulatory tool for macrophages in contrast to monocytes. It also appears that different cell types show varying affinities for adenosine and its analogues. This may implicate selective regulatory functions for cells that are located close together, as in the vessel wall. The presence of A 2 receptors on 7-day cultured human MNPs could be confirmed by the induction of adenylyl cyclase activity (Fig 4) . The elevation of intracellular cAMP has been shown to be responsible for the activation of cholesteryl ester hydrolases 49 and to influence uptake and degradation of lipoproteins. 50 Usually, adenosine and its analogues are supposed to decrease intracellular Ca 2+ levels. 51 In our experiments with 7-day cultured human MNPs, it could be shown for the first time that adenosine activates two intracellular messengers: cAMP and Ca 2+ (Fig 3, Table 2 ). The activation of Ca 2+ induced by P 2 and P] receptors has been shown to be due to the activation of intracellular Ca 2+ stores in 7-day cultured human MNPs. 52 It was shown that both adenosine and ATP analogues inhibit the uptake of chemically modified LDL via scavenger-receptor activities in 7-day cultured human MNPs in a dose-dependent manner (Figs 5 and 6 ). Binding and uptake of fluorescently labeled lipoproteins cannot be discriminated by this method. However, it is known that binding of AcLDL is rapidly followed by interaalization. 44 In our own experiments using confocal laser scan microscopy, it is demonstrated that most of the cell-associated Dil-AcLDL is internalized under the incubation conditions used for flow cytometry (data not shown). Thus, it may be assumed that most of the Dil-AcLDL fluorescence is in fact intracellular. The regulation of different types of scavenger receptors is yet poorly understood. 2 However, oxidized LDL as a natural ligand for the scavenger receptor stimulates phosphoinositol turnover in smooth muscle cells that might be associated with receptor-mediated endocyto-sis. 53 This stimulation was prevented by compounds that are well recognized to inhibit endocytosis of both hormonal and lipoprotein receptors. The mechanism of action of these hormones on phosphoinositide turnover involves the coupling of phospholipase C to receptors via G proteins. 17 ATP-yS, as a ligand of P 2 receptors, activates, as far as is known, a phospholipase C that is coupled via G proteins to the receptor, leading to formation of inositol-l,4,5-trisphosphate and 1,2-diacylgrycerol. Inositol-l,4,5-trisphosphate induces a Ca 2+ mobilization from intracellular stores, and 1,2-diacylglycerol activates protein kinase C. In our experiments with 7-day cultured human MNPs, the A 2 ligand CGS 21680 activates both cAMP and Ca 2+ signals. Additionally, the intracellular cAMP is also increased by ATP-yS in 7-day cultured human MNPs, and both ligands inhibit the uptake of AcLDL in 7-day cultured human MNPs. Therefore, it is suggested that both second messengers are involved in the regulation of endocytotic processes that play an important role for the internalization of scavenger receptors. This is in accordance with literature data showing that the level of second messengers is altered in atherosclerotic plaques. A dramatic decrease of [cAMP] , is observed in fatty streaks, which is explained by a decrease in the basal activity of adenylyl cyclase. 54 In conclusion, it could be demonstrated that (1) 1-day cultured human MNPs are not susceptible to extracellular adenosine, since they lack adenosine receptors, (2) only 7-day cultured MNPs express A 2 receptors, (3) B^ of P^ receptors is increased twofold during differentiation, (4) CGS 21680 as a ligand for the Pj receptor and ATP-yS as a ligand for the P 2 receptor induce both a transient Ca 2+ flux and an elevation of [cAMPJi, and (5) uptake of modified LDL is inhibited by P t and P 2 ligands in a concentrationdependent manner, which might be important in preventing foam cell formation.
